Jefferies Financial Group’s Charles River Laboratories CRL Stock Holding History

Jefferies Financial Group’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,000	Closed	-$782K	–	1899
2025 Q3	$782K	Sell	5,000 -3,872	-44%	-$615K	﹤0.01%	948
2025 Q2	$1.35M	Sell	8,872 -4,742	-35%	-$632K	0.01%	635
2025 Q1	$2.05M	Sell	13,614 -4,188	-24%	-$702K	0.02%	576
2024 Q4	$3.29M	Buy	17,802 +12,353	+227%	+$2.38M	0.02%	500
2024 Q3	$1.07M	Buy	+5,449	New	+$1.13M	0.01%	768
2024 Q2	–	Sell	-8,720	Closed	-$2.36M	–	1489
2024 Q1	$2.36M	Buy	+8,720	New	+$2.08M	0.02%	536
2023 Q4	–	Sell	-1,199	Closed	-$235K	–	1747
2023 Q3	$235K	Buy	+1,199	New	+$246K	﹤0.01%	1291

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Jefferies Financial Group's CRL Position: Q4 2025 in Review

Jefferies Financial Group sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 5,000 shares — an estimated $782K sold.

Jefferies Financial Group first reported a position in CRL in Q3 2023 and held it in 7 quarters. The position peaked at $3.29M in Q4 2024. 581 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

Jefferies Financial Group reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
Jefferies Financial Group sold 5,000 Charles River Laboratories shares in Q4 2025, an estimated $782K.
Jefferies Financial Group first reported a position in Charles River Laboratories in Q3 2023 and held it in 7 quarters.
Jefferies Financial Group's Charles River Laboratories position peaked at $3.29M in Q4 2024.
581 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on Jefferies Financial Group's 13F filing for Q4 2025, filed 9 Feb 2026.